Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV005402800 | SCV006064681 | uncertain significance | Cardiomyopathy | 2024-10-28 | criteria provided, single submitter | clinical testing | This missense variant replaces histidine with tyrosine at codon 222 of the LMNA protein. Computational prediction tool is inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in homozygous state an individual affected with Emery-Dreifuss muscular dystrophy, as well as in both heterozygous unaffected carrier parents (PMID: 10739764, 14659775). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
OMIM | RCV000015583 | SCV000035848 | pathogenic | Emery-Dreifuss muscular dystrophy 3, autosomal recessive | 2000-04-01 | no assertion criteria provided | literature only | |
Gene |
RCV004577319 | SCV000058064 | not provided | Emery-Dreifuss muscular dystrophy 2, autosomal dominant | no assertion provided | literature only | ||
Epithelial Biology; Institute of Medical Biology, |
RCV000057440 | SCV000088554 | not provided | not provided | no assertion provided | not provided |